The article highlights the major challenge of limb amputation in the Caribbean and its effects on the patient’s quality of life, stressors on the family and the burden on the healthcare system. Four clinical cases are presented with various wound aetiologies and comorbidities; these patients were candidates for limb amputation. A reassessment of the traditional wound management approach paradigmatically shifted to a new strategy. This strategy includes clinically effective, easy-to-apply, and affordable products that help to reduce limb amputation, resulting in limb salvage.

Authors:

Larry G. Baratta and Yvonne Braithwaite Superville

Larry G. Baratta is International Medical Director, Chief Medical Officer - World Wide Wound Care, LLC;

Yvonne Braithwaite is Chief Executive Officer - Rovon Foot and Wound Care Clinic

MANAGING THE CHALLENGES AND RISKS OF INFECTION IN WOUND CARE

USE OF DIFFERENT ANTISEPTICS IN PRACTICE

WOUND CLEANSING AND TIPS FOR BEST PRACTICE

GUIDANCE AND PATHWAYS FOR ANTISEPTIC USE

THE IMPORTANCE OF AN ANTIMICROBIAL STEWARDSHIP-FOCUSED APPROACH

EXPERT PANEL

Harikrishna K. R. Nair (Chair), Professor and Head of the Wound Care Unit, Department of Internal Medicine, Kuala Lumpur Hospital, Malaysia

Beata Mrozikiewicz-Rakowska, President of the Polish Wound Management Association, Department of Endocrinology, Medical Centre of Postgraduate Education, Warsaw, Poland

Debora Sanches Pinto, Assistant Physician, Division of Plastic Surgery and Burns, University of São Paulo Faculty of Medicine Clinics Hospital, São Paulo, Brazil

Ewa K. Stuermer, Professor, Surgical Head of the Comprehensive Wound Center, Head of Translational Research, Department for Vascular Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Johannes Matiasek, Associate Professor and Specialist in Plastic, Reconstructive and Aesthetic Surgery, Medizin am Kärntner Ring, Vienna, Austria

Johanna Sander, Head of Advanced Wound Care, 2 Military Hospital, Cape Town, South Africa

José Luis Lázaro-Martínez, Professor, The Complutense University of Madrid; Clinical Director, Complutense University Podiatric Clinic; Head of Diabetic Foot Unit, University Podiatric Clinic, Madrid, Spain

Karen Ousey, Professor of Skin Integrity, Director for the Institute of Skin Integrity and Infection Prevention, University of Huddersfield, United Kingdom

Ojan Assadian, Medical Director, Hospital Wiener Neustadt, Austria; Professor Emeritus, University of Huddersfield, United Kingdom

Paul J. Kim, Medical Director, University of Texas Southwestern Medical Center; Professor, Department of Plastic Surgery and Orthopaedic Surgery, University of Texas Southwestern, United States

Steven L. Percival, Professor (Honorary), University of Manchester, United Kingdom; CEO and Director, Biofilm Centre, 5D Health Protection Group Ltd, Liverpool, United Kingdom

PUBLISHED BY: Wounds International 108 Cannon Street London EC4N 6EU, UK

Tel: + 44 (0)20 7627 1510 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 www.woundsinternational.com

© Wounds International, 2023

The meeting and this document have been supported by B Braun, Bactiguard, Schülke and Urgo Medical.

The views in this document do not necessarily reflect those of the sponsors.

How to cite this document: Nair HKR et al (2023) International Consensus Document: Use of wound antiseptics in practice. Wounds International. Available online at www.woundsinternational. com

Chronic wounds are a substantial burden on healthcare systems worldwide, with their management accounting for a significant portion of healthcare budgets. Given the rising prevalence of wounds and the growing strain on healthcare resources, there is an urgent need for more efficient treatment options in wound care.

Authors:

Zena Moore and Sebastian Probst

Zena Moore PhD, MSc, FFNMRCSI, PG Dip, RGN is Professor and Head of the School of Nursing and Midwifery, Director of the Skin Wounds and Trauma Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland;

Sebastian Probst DClinPrac, MNS, BNS, RN is Full Professor of Tissue Viability and Wound Care, Geneva School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland, Care Directorate, University Hospital Geneva, Switzerland and Adjunct Professor, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia

* The data set used to create the 3.5 billion hour model (Moore et al, 2022), revealed that globally, 4,011,188,929 hours are spent on dressing changes in the community per year. ALLEVYN LIFE Dressing as part of a shared wound care approach has the potential to release 10.8% (433,208,404) of these hours (Joy et al, 2015; Moore et al, 2022; Rossington et al, 2013; Simon and Bielby, 2014; Tiscar-González et al, 2021).

The Wound Care Pathway was developed in 2020/21 to provide a practical, evidence-based step-by-step approach towards wound healing (Dowsett et al, 2021). Healthcare providers who use the pathway asked for more detailed guidance for specific wound types. A group of wound care experts, comprised of physicians, nurses and researchers, undertook a process to expand the international consensus on wound healing by developing wound type-specific pathways for diabetic foot ulcers, venous leg ulcers, skin tears, pressure injuries/pressure ulcers and surgical wound dehiscence. The objective was to take complex research evidence and translate it into simple and practical treatment guidance for the non-specialist, for the five most common wound types. The systematic approach to wound care provided in the wound care pathway and in the wound type specific pathways is designed with the goal of achieving a shorter way to wound healing by helping healthcare providers focus on healing wounds not just dressing wounds.

Authors:

Terry Swanson, Kimberly Bain,Caroline Dowsett, Jose Ramon March Garcia, Emily Greenstein, David Keast, Long Zhang, Mark Bain, Hester Colboc and Christoffer Hoffmann

Terry Swanson is Nurse Practitioner

Wound Management, Warrnambool, Vic. Australia;

Kimberly Bain is Senior Partner - Consensus Building, BainGroup Consulting, Canada;

Caroline Dowsett is Nurse Specialist Tissue Viability, East London NHS Foundation Trust London, UK;

Jose Ramon March Garcia is Vascular Surgeon Getafe University Hospital (Madrid), Spain;

Emily Greenstein is Certified Nurse Practitioner at Sanford Health in Fargo, USA;

David Keast is Associate Scientist, Lawson Health Research institute, Canada;

Long Zhang is Vascular Surgeon, Wound Healing Center, Peking University Third Hospital,China;

Mark Bain is Senior Partner, Data Strategy, BainGroup Consulting, Canada;

Hester Colboc is Dermatologist & Gerontologist, Rothschild Hospital, Paris, France;

Christoffer Hoffmann is Senior Medical Specialist, Coloplast A/S, Denmark